Medtech startup is developing off-the-shelf cancer immunotherapies designed to treat a broad patient population
Epitopea has raised €12M across 1 funding round from 6 investors, most recently a Seed round in Apr 2022. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-25 | Seed | €12M |
| Advent Life Sciences,Cambridge Innovation Capital,CTI Life Sciences,Fonds de solidarité FTQ,Harrington Discovery Institute,Novateur Ventures |
| View deal → |
